XML 48 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Award Plans and Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2019
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s consolidated statements of operations for the fiscal years ended March 31, 2019, 2018 and 2017:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2019

 

 

 

2018

 

 

 

2017

 

 

 

(in $000's)

 

Cost of revenue

 

$

2,643

 

 

$

1,721

 

 

$

1,061

 

Research and development

 

 

9,312

 

 

 

5,895

 

 

 

6,050

 

Selling, general and administrative

 

 

42,539

 

 

 

32,737

 

 

 

25,755

 

 

 

$

54,494

 

 

$

40,353

 

 

$

32,866

 

Components of Stock-Based Compensation

The components of stock-based compensation for the fiscal years ended March 31, 2019, 2018 and 2017 were as follows:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2019

 

 

 

2018

 

 

 

2017

 

 

 

(in $000's)

 

Restricted stock units

 

$

45,998

 

 

$

34,559

 

 

$

26,570

 

Stock options

 

 

7,445

 

 

 

5,202

 

 

 

5,829

 

Employee stock purchase plan

 

 

1,051

 

 

 

592

 

 

 

467

 

 

 

$

54,494

 

 

$

40,353

 

 

$

32,866

 

Summary of Stock Option Activity

The following table summarized stock option activity for the fiscal year ended March 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

1,282

 

 

$

46.81

 

 

 

5.31

 

 

$

313,158

 

Granted

 

 

81

 

 

 

379.90

 

 

 

 

 

 

 

 

 

Exercised

 

 

(485

)

 

 

26.68

 

 

 

 

 

 

 

 

 

Cancelled and expired

 

 

(25

)

 

 

138.68

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

853

 

 

$

87.14

 

 

 

5.57

 

 

$

176,629

 

Exercisable at end of period

 

 

623

 

 

$

40.72

 

 

 

4.58

 

 

$

152,598

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted The weighted average grant-date fair values and weighted average assumptions used in the calculation of fair value of options granted during the fiscal years ended March 31, 2019, 2018 and 2017 was as follows:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2019

 

 

 

2018

 

 

 

2017

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average grant-date fair value

 

$

141.47

 

 

$

52.34

 

 

$

42.40

 

Risk-free interest rate

 

 

2.91

%

 

 

1.87

%

 

 

1.41

%

Expected option life (years)

 

 

4.04

 

 

 

4.07

 

 

 

4.14

 

Expected volatility

 

 

42.8

%

 

 

43.5

%

 

 

48.9

%

Restricted Stock Units  
Summary of Restricted Stock Units Activity

The following table summarizes restricted stock unit activity for the fiscal year ended March 31, 2019:

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

880

 

 

$

109.01

 

Granted

 

 

195

 

 

 

376.95

 

Vested

 

 

(427

)

 

 

103.54

 

Forfeited

 

 

(28

)

 

 

189.05

 

Restricted stock units at end of period

 

 

620

 

 

$

193.53

 

Monte Carlo Simulation Model to Estimate Grant-Date Fair Value of Restricted Stock Units

The table below sets forth the assumptions used to value the market-based awards and the estimated grant-date fair value:

 

 

 

June 2015

Awards

 

 

November 2016

Awards

 

Risk-free interest rate

 

 

1.10

%

 

 

0.90

%

Dividend yield

 

 

0

%

 

 

0

%

Remaining performance period (years)

 

 

0.21

 

 

 

0.21

 

Expected volatility

 

 

47.2

%

 

 

50.6

%

Estimated grant date fair value (per share)

 

$   93.49 - 107.10

 

 

$

62.55

 

Target performance (number of shares)

 

 

107,660

 

 

 

41,526